标题
Revisiting determinants of prognosis in cutaneous melanoma
作者
关键词
-
出版物
CANCER
Volume 121, Issue 23, Pages 4108-4123
出版商
Wiley
发表日期
2015-08-27
DOI
10.1002/cncr.29634
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma
- (2015) P. Gerami et al. CLINICAL CANCER RESEARCH
- C-Reactive Protein As a Marker of Melanoma Progression
- (2015) Shenying Fang et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
- (2015) Pedram Gerami et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Identification of Metastasis-Suppressive microRNAs in Primary Melanoma
- (2015) Doug Hanniford et al. JNCI-Journal of the National Cancer Institute
- Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
- (2015) Cristina Fortes et al. Journal of Translational Medicine
- MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations withBRAFmutation and patient prognosis
- (2015) Varsha Tembe et al. Pigment Cell & Melanoma Research
- Identification of Metastasis-Suppressive microRNAs in Primary Melanoma
- (2015) Doug Hanniford et al. JNCI-Journal of the National Cancer Institute
- Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
- (2015) Nancy E. Thomas et al. JAMA Oncology
- A highly recurrent RPS27 5’UTR mutation in melanoma
- (2015) Ken Dutton-Regester et al. Oncotarget
- Controversies in the Management of Advanced Melanoma
- (2014) Anthony Jarkowski et al. ANNALS OF PHARMACOTHERAPY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
- (2014) Nathaniel H. Fleming et al. CANCER
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease
- (2014) Shanthi Sivendran et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
- (2014) Helena Pópulo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
- (2014) Klaus G. Griewank et al. JNCI-Journal of the National Cancer Institute
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Clinical and pathological associations of the activatingRAC1P29S mutation in primary cutaneous melanoma
- (2014) Victoria J. Mar et al. Pigment Cell & Melanoma Research
- Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma
- (2014) William R. Jeck et al. Pigment Cell & Melanoma Research
- Immunoscore: a new possible approach for melanoma classification
- (2014) Mariaelena Capone et al. Journal for ImmunoTherapy of Cancer
- Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
- (2014) Evan J Lipson et al. Journal for ImmunoTherapy of Cancer
- Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study
- (2013) Nancy E. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition
- (2013) Heidi L. Gold et al. MOLECULAR CANCER RESEARCH
- HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome
- (2013) J Wardwell-Ozgo et al. ONCOGENE
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation
- (2012) J S Hall et al. BRITISH JOURNAL OF CANCER
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
- (2012) Nora Pencheva et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
- (2012) K. Harbst et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
- (2012) Farhad Azimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Histology-Specific MicroRNA Alterations in Melanoma
- (2012) Laura Poliseno et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma
- (2012) Graham J. Mann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Serum microRNAs as biomarkers for recurrence in melanoma
- (2012) Erica B Friedman et al. Journal of Translational Medicine
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma
- (2012) J R Todd et al. ONCOGENE
- A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts
- (2012) Stefanie Meyer et al. PLoS One
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- An Attempt at a Molecular Prediction of Metastasis in Patients with Primary Cutaneous Melanoma
- (2012) Melanie Gschaider et al. PLoS One
- Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression
- (2012) Léon C. van Kempen et al. VIRCHOWS ARCHIV
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis
- (2011) Avital Gaziel-Sovran et al. CANCER CELL
- Genetic alterations of PTEN in human melanoma
- (2011) Almass-Houd Aguissa-Touré et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- AJCC melanoma staging update: impact on dermatopathology practice and patient management
- (2011) Adriano Piris et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Superficial spreading and nodular melanoma are distinct biological entities
- (2011) Holly S. Greenwald et al. MELANOMA RESEARCH
- Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
- (2011) Bianca Devitt et al. Pigment Cell & Melanoma Research
- Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor
- (2011) Glen M. Boyle et al. Pigment Cell & Melanoma Research
- Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma
- (2010) Uma N. M. Rao et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
- (2010) Jiamin Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics
- (2010) Scott E. Woodman et al. BIOCHEMICAL PHARMACOLOGY
- Signatures of MicroRNAs and Selected MicroRNA Target Genes in Human Melanoma
- (2010) D. Philippidou et al. CANCER RESEARCH
- Patterns of Expression of DNA Repair Genes and Relapse From Melanoma
- (2010) R. Jewell et al. CLINICAL CANCER RESEARCH
- Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
- (2010) M. F. Segura et al. CLINICAL CANCER RESEARCH
- Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
- (2010) J. A. Ellerhorst et al. CLINICAL CANCER RESEARCH
- Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases
- (2010) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarkers: The Useful and the Not So Useful—An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma
- (2010) Bonnie E. Gould Rothberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
- (2010) Stefano Caramuta et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma
- (2010) Carmit Levy et al. MOLECULAR CELL
- The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell Invasiveness
- (2010) Joseph Mazar et al. PLoS One
- Acral Lentiginous Melanoma
- (2009) Porcia T. Bradford et al. ARCHIVES OF DERMATOLOGY
- Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival
- (2009) C. Conway et al. CLINICAL CANCER RESEARCH
- A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
- (2009) M. Kashani-Sabet et al. CLINICAL CANCER RESEARCH
- Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
- (2009) M. Mandalà et al. EUROPEAN JOURNAL OF CANCER
- Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms
- (2009) Bonnie E. Gould Rothberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin
- (2009) Christoph Lahtz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
- (2009) Bonnie E. Gould Rothberg et al. JNCI-Journal of the National Cancer Institute
- The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
- (2008) Adam I Riker et al. BMC Medical Genomics
- Changes in the presentation of nodular and superficial spreading melanomas over 35 years
- (2008) Melanie A. Warycha et al. CANCER
- Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients
- (2008) Georg Brunner et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started